Cargando…

The Role of Antibody Testing for SARS-CoV-2: Is There One?

The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) brought with it rapid development of both molecular and serologic assays for identification of COVID-19 infections. While Food and Drug Administration (FDA) emergency use authorization (EUA) is required for clinical applic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Theel, Elitza S., Slev, Patricia, Wheeler, Sarah, Couturier, Marc Roger, Wong, Susan J., Kadkhoda, Kamran
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Microbiology 2020
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7383527/ https://www.ncbi.nlm.nih.gov/pubmed/32350047 http://dx.doi.org/10.1128/JCM.00797-20

Ejemplares similares

Considerations from the College of American Pathologists for Implementation of an Assay for SARS-CoV-2 Testing after a Change in Regulatory Status
por: Peaper, David R., et al.
Publicado: (2021)

Immunity to SARS-CoV-2: What Do We Know and Should We Be Testing for It?
por: Misra, Anisha, et al.
Publicado: (2022)

Performance Characteristics of Four High-Throughput Immunoassays for Detection of IgG Antibodies against SARS-CoV-2
por: Theel, Elitza S., et al.
Publicado: (2020)

Detection of SARS-CoV-2 IgG antibodies in dried blood spots
por: Turgeon, Coleman T., et al.
Publicado: (2021)

Screening for SARS-CoV-2: Health Policy Implications in Low- and Middle-Income Countries
por: Hashmi, Shahrukh K., et al.
Publicado: (2020)

Validation of a multiplex flow immunoassay for detection of IgG antibodies against SARS-CoV-2 in dried blood spots
por: Turgeon, Coleman T., et al.
Publicado: (2021)

Using SARS-CoV-2 Antibody Testing in COVID-19 Research
por: Amraotkar, Alok R., et al.
Publicado: (2023)

One year of SARS-CoV-2 evolution
por: Wu, Aiping, et al.
Publicado: (2021)

Autoimmune Encephalitis After SARS-CoV-2 Infection: Case Frequency, Findings, and Outcomes
por: Valencia Sanchez, Cristina, et al.
Publicado: (2021)

Avidity assay to test functionality of anti-SARS-Cov-2 antibodies
por: Gaspar, Emanuelle Baldo, et al.
Publicado: (2021)

Trends in Q fever serologic testing by immunofluorescence from four large reference laboratories in the United States, 2012–2016
por: Miller, Halie K., et al.
Publicado: (2018)

Combined treatment of molnupiravir and favipiravir against SARS-CoV-2 infection: One + zero equals two?
por: Eloy, Philippine, et al.
Publicado: (2021)

Evaluation of the genalyte maverick SARS-CoV-2 multi-antigen serology panel
por: Donato, Leslie J., et al.
Publicado: (2021)

Waning antibodies to SARS-CoV-2 – Don't panic
por: Meyer, Benjamin
Publicado: (2021)

Molecular and Direct Detection Tests for Treponema pallidum Subspecies pallidum: A Review of the Literature, 1964–2017
por: Theel, Elitza S, et al.
Publicado: (2020)

Performance Characteristics of High-Throughput Serologic Assays for Severe Acute Respiratory Syndrome Coronavirus 2 with Food and Drug Administration Emergency Use Authorization: A Review
por: Theel, Elitza S.
Publicado: (2022)

Non-neutralizing antibodies and limitations of serologic testing for severe acute respiratory syndrome coronavirus 2 in patients receiving immunoglobulin replacement products
por: Manian, Deepti Vellaichamy, et al.
Publicado: (2021)

Diagnostic Testing for Zika: Observing Rapid Translation During a Public Health Emergency
por: Kurani, Shaheen, et al.
Publicado: (2017)

Report from the American Society for Microbiology COVID-19 International Summit, 23 March 2020: Value of Diagnostic Testing for SARS–CoV-2/COVID-19
por: Patel, Robin, et al.
Publicado: (2020)

A rapid and affordable point of care test for antibodies against SARS-CoV-2 based on hemagglutination and artificial intelligence interpretation
por: Redecke, Vanessa, et al.
Publicado: (2021)

Group Testing for SARS-CoV-2: Forward to the Past?
por: Pouwels, Koen B., et al.
Publicado: (2020)

SARS-CoV-2 antibody-based SURVEILLANCE: New light in the SHADOW
por: Plebani, Mario
Publicado: (2020)

Searching for escape-resistant anti–SARS-CoV-2 neutralizing antibodies
por: Mahla, Ranjeet Singh, et al.
Publicado: (2022)

Preexisting vs. de novo antibodies against SARS-CoV-2 in individuals without or with virus infection: impact on antibody therapy, vaccine research and serological testing
por: Muthumani, Kar, et al.
Publicado: (2021)

Guillain-Barré Syndrome in a Patient With Evidence of Recent SARS-CoV-2 Infection
por: Naddaf, Elie, et al.
Publicado: (2020)

Unrecognized severe acute respiratory coronavirus virus 2 (SARS-CoV-2) seroprevalence among healthcare personnel in a low-prevalence area
por: Shah, Vishal P., et al.
Publicado: (2020)

My Experience with SARS-CoV-2, with a Focus on Testing
por: Cotter, Peggy A.
Publicado: (2020)

Evaluation of High-Throughput Serological Tests for SARS-CoV-2
por: Loeffelholz, Michael J.
Publicado: (2020)

Disease Prevalence Matters: Challenge for SARS-CoV-2 Testing
por: Lau, Chin-Shern, et al.
Publicado: (2021)

339. Assessing Utilization of the Venereal Disease Research Laboratory Test in Cerebrospinal Fluid for the Diagnosis of Neurosyphilis: A Cohort Study
por: Sytsma, Terin, et al.
Publicado: (2020)

Twelve lateral flow immunoassays (LFAs) to detect SARS-CoV-2 antibodies
por: Owen, Sophie I., et al.
Publicado: (2022)

Relevant of neutralizing antibody during SARS-CoV-2 infection and their therapeutic usage
por: Gupta, Sneh Lata, et al.
Publicado: (2022)

RT-qPCR Testing of SARS-CoV-2: A Primer
por: Bustin, Stephen A., et al.
Publicado: (2020)

Identification of SARS-CoV-2 spike mutations that attenuate monoclonal and serum antibody neutralization
por: Liu, Zhuoming, et al.
Publicado: (2021)

A rapid and affordable point-of-care test for detection of SARS-CoV-2-specific antibodies based on hemagglutination and Artificial Intelligence-based image interpretation
por: Redecke, Vanessa, et al.
Publicado: (2021)

Neutralizing and cross-reacting antibodies: implications for immunotherapy and SARS-CoV-2 vaccine development
por: Cohen, Samuel A., et al.
Publicado: (2020)

SARS-CoV-2 variants: Subversion of antibody response and predicted impact on T cell recognition
por: Altmann, Daniel M., et al.
Publicado: (2021)

The First Quarter of SARS-CoV-2 Testing: the University of Washington Medicine Experience
por: Greninger, Alexander L., et al.
Publicado: (2020)

SARS-CoV-2 testing in infertile patients: different recommendations in Europe and America
por: La Marca, Antonio, et al.
Publicado: (2020)

Detect to protect: pneumoperitoneum gas samples for SARS-CoV-2 and biohazard testing
por: Cicuttin, Enrico, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_omgggjbekdluic3a5bu7bsitgg